Cargando…
β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology
Alzheimer’s disease (AD) is a progressive, late-onset dementia with no effective treatment available. Recent studies suggest that AD pathology is driven by age-related changes in metabolism. Alterations in metabolism, such as placing patients on a ketogenic diet, can alter cognition by an unknown me...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507727/ https://www.ncbi.nlm.nih.gov/pubmed/32958021 http://dx.doi.org/10.1186/s12974-020-01948-5 |